Background: The effects of long COVID are experienced by the majority of COVID-19 survivors in various forms, including cardiovascular diseases and often elevated D-dimer levels. Objective: This study ...

Use of clinical decision rules in conjunction with D-dimer thresholds adjusted higher based on either age or pretest probability is acceptably safe for ruling out acute pulmonary embolism (PE) without ...

Tampa, FL (Oct. 26, 2021) --A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized ...

February 10, 2023 – Measurement of plasma D-dimer levels – a test more commonly used to detect blood-clotting disorders – can provide useful information when making the difficult diagnosis of ...

A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more people with low to intermediate suspicion in the first place. The ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out ...

Elevated levels of soluble urokinase plasminogen activator receptor (suPAR) — a protein produced by the immune system in response to SARS-CoV-2 infection — may predict the formation of clots in ...

Does an elevated ultrasensitive D-dimer level in a patient whose pre-test probability puts him at low risk for pulmonary embolus (PE) indicate an increased risk for PE or deep venous thrombosis (DVT)?